Belgium – Research and development services and related consultancy services – Multiple Sourcing Framework Contracts to Speed up the Development of and Access to Innovative Medical Countermeasures: Next-Generation Influenza Vaccines

Description

This call for tenders aims to speed up the development of next generation influenza vaccines that could be produced in rapidly scalable manufacturing platforms (e.g. nucleic acid approaches and/or production in scalable eukaryotic or bacterial cell culture, in plants or via in vitro transcription), could support products utilising novel administration routes (e.g. nasal, oral or through microneedle patches), confer mucosal immunity, target potentially pandemic influenza A viruses or could be rapidly adapted to pandemic influenza A viruses, which are protective across influenza subtypes or across alpha-influenza viruses, and/or possess intrinsic immunogenicity without the addition of adjuvants. The call will be implemented via a competitive development in phases as foreseen under Pre-Commercial Procurement.

Key facts

Procedure

neg-w-call

Framework agreement

Yes — a framework or dynamic purchasing system, not a single contract

Submit via

https://webgate.ec.europa.eu/digit/opsys/esubmission?cftUuid=238003cb-2e50-4526-b994-5b2c972ed895

Contact

hadea-procurement@ec.europa.eu

Category

services